HomeALZCUR • STO
add
AlzeCure Pharma AB
Previous close
kr 2.12
Day range
kr 2.00 - kr 2.16
Year range
kr 0.77 - kr 4.95
Market cap
235.57M SEK
Avg Volume
52.87K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.05M | 29.85% |
Net income | -10.02M | -34.13% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.74M | -31.73% |
Effective tax rate | 0.04% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.19M | 51.04% |
Total assets | 66.59M | 56.48% |
Total liabilities | 15.93M | 126.25% |
Total equity | 50.66M | — |
Shares outstanding | 114.91M | — |
Price to book | 4.82 | — |
Return on assets | -60.55% | — |
Return on capital | -83.97% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -10.02M | -34.13% |
Cash from operations | -7.62M | 5.55% |
Cash from investing | — | — |
Cash from financing | 54.23M | 1,524.72% |
Net change in cash | 46.61M | 1,085.71% |
Free cash flow | -2.32M | 57.57% |
About
Founded
2012
Website
Employees
11
